Stay updated on Daratumumab Combo in Severe Renal Impairment Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo in Severe Renal Impairment Clinical Trial page.

Latest updates to the Daratumumab Combo in Severe Renal Impairment Clinical Trial page
- ChecktodayChange DetectedAdded topic tag 'Multiple myeloma' and a related topic link to MedlinePlus Genetics.SummaryDifference0.2%

- Check8 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 on the page.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded a site revision banner: Revision: v3.4.1. Removed the funding status notice and certain navigation topics (e.g., Multiple myeloma, MedlinePlus Genetics) and the prior Revision: v3.4.0.SummaryDifference0.6%

- Check22 days agoChange DetectedA site-wide notification about a lapse in government funding and the NIH Clinical Center's operating status was added to the page, including links to cc.nih.gov and opm.gov. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check29 days agoChange DetectedThe page now shows a glossary option and related topic links (e.g., Multiple myeloma, MedlinePlus Genetics), and metadata labels were updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' while older labels like 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed.SummaryDifference0.4%

- Check36 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed as part of the site’s release notes; this update does not affect study content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Combo in Severe Renal Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Severe Renal Impairment Clinical Trial page.